Cerapedics Closes $11 Million Series D Financing

Cerapedics completed a US $11MM Series D financing. Funds will support expanded commercialization of i-FACTOR™ Peptide Enhanced Bone Graft, which received FDA premarket approval in 4Q15 for use in anterior cervical discectomy and fusion (ACDF) to treat degenerative disc disease. Proceeds will also further development of synthetic small peptide...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us